Dear colleagues,

From my position as Chairman of the  1st International CRS Congress, which will be held in Athens on 27-28 May 2015, it is my pleasure to invite you all to Athens.

This congress program includes both small molecules (innovative drugs-generics) and biotechnological drugs-biosimilars in parallel sessions. The program on small molecules includes drug discovery and design, drug delivery and nanotechnology, pharmacokinetic-pharmacodynamic and pharmacogenomics studies for the rational therapeutic use of drugs.

In parallel, the recent developments in the basic research of biotechnologically produced macromolecules such as dynamic configuration of proteins, formulation of biotechnological molecules, proteomics, therapeutic targeting of biological pathways and biomarkers will be discussed; also, applied aspects of the clinical practice of biotechnological drugs like the interchangeability of biotechnological drugs and biosimilars, the optimization of therapeutic use of monoclonal antibodies in oncology and rheumatology along with the health economics of biotechnological medicines and biosimilars will be presented. Eminent world-wide scientists are listed among the confirmed speakers.

In order to guarantee the quality of future research and new practical applications, a dialogue between experienced colleagues, young scientists and professionals will be encouraged.

I invite you all to spend a few days in Athens and share your knowledge with high-level scientists from all over the world.

Professor Panos Macheras

Chairman of the Congress
Faculty of Pharmacy
University of Athens

Για περισσότερες πληροφορίες, επισκεφθείτε τον ακόλουθο σύνδεσμο: http://www.afea.gr/crscongress